Showing results (31-40 of 223) with videos related to
Sort By:
Pageof 23
Blood|October 26, 2007
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphomaElizabeth Fox, Bassem I Razzouk, Brigitte C Widemann, et al.Cancer Chemotherapy and Pharmacology|May 25, 2004
Pharmacokinetics of carboplatin administered with lobradimil to pediatric patients with brain tumorsKatherine Warren, Anne Gervais, Alberta Aikin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2012
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium reportBrigitte C Widemann, Aerang Kim, Elizabeth Fox, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcomeBrigitte C Widemann, Frank M Balis, AeRang Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2013
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinomaElizabeth Fox, Brigitte C Widemann, Meredith K Chuk, et al.Cancer Chemotherapy and Pharmacology|October 3, 2007
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitisRonald J Bernardi, Lisa Bomgaars, Elizabeth Fox, et al.Pediatric Blood & Cancer|September 11, 2012
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromasAeRang Kim, Eva Dombi, Kathleen Tepas, et al.Urology|April 29, 2018
Case Report: Nephron-sparing Surgery in a Patient With Bilateral Multifocal Wilms TumorDiana K Bowen, Christopher J Long, Frank M Balis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromasBrigitte C Widemann, Wanda L Salzer, Robert J Arceci, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumorsElizabeth Fox, John M Maris, Brigitte C Widemann, et al.Pageof 23